Page 89 - Amgen News Today

Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor U.S. sales of its biosimilar version of AbbVie’s blockbuster arthritis treatment Humira. The German drugmaker said it planned to reduce its customer-facing teams in favor of a hybrid in-person and virtual sales model by June 30, in large part because pharmacy benefit managers (PBMs) had kept branded Humira on their lists of medicines for reimbursement. That choice has led to less uptake of biosimila...

Pharmaceutical executive Scott Plesha named CEO Lead product ZELSUVMI expected to be commercially available in late 2024 ...

Goldman Sachs just shared their 22 best stock ideas for strong risk-adjusted returns as markets rally in a better-than-feared market.

The indices are projected to complete April at new highs. Disney is the highest rated buy recommendation of the Dow 30. It is also the top pick, long or short.

Cahaba Wealth Management Inc. cut its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,063 shares of the medical research company’s stock after selling 114 shares during […]

BioPharma

Howland Capital Management LLC increased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 12.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,225 shares of the medical research company’s stock after buying an additional 245 shares during the quarter. […]

White Lighthouse Investment Management Inc. raised its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,300 shares of the medical research company’s stock after buying an additional 55 shares […]

White Lighthouse Investment Management Inc. boosted its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 3,300 shares of the medical research company’s stock after buying an additional 55 shares during the quarter. White Lighthouse Investment Management Inc.’s holdings in Amgen were worth […]

Hartford Investment Management Co. cut its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 36,057 shares of the medical research company’s stock after selling 832 shares during the period. Hartford Investment Management […]